Letter: Revisiting NAC’s Multifaceted Role in Asthma Management: A Delicate Balance Between Anti‐Inflammatory Potential and Airway Defense Attenuation

Abstract

Get full access to this article

View all access options for this article.

References

Smieško

, Mažerik

, Gondáš

, et al. N-Acetylcysteine and its therapeutic potential in an animal model of allergic asthma. J Aerosol Med Pulm Drug Deliv, 2025; 38(3):118–126; doi: 10.1089/jamp.2024.0049

Del Donno

, Bittesnich

, Chetta

, et al. The effect of inflammation on mucociliary clearance in asthma. Chest, 2000; 118(4):1142–1149; doi: 10.1378/chest.118.4.1142

Raby

, Michaeloudes

, Tonkin

, et al. Mechanisms of airway epithelial injury and abnormal repair in asthma and COPD. Front Immunol, 2023; 14:1201658; doi: 10.3389/fimmu.2023.1201658

Dodd

, Dean

, Copolov

, et al. N-acetylcysteine for antioxidant therapy: Pharmacology and clinical utility. Expert Opin Biol Ther, 2008; 8(12):1955–1962; doi: 10.1517/14728220802517901

Lee

P-H

, Hong

, Jang

A-S

. N-acetylcysteine decreases airway inflammation and responsiveness in asthma by modulating claudin 18 expression. Korean J Intern Med, 2020; 35(5):1229–1237; doi: 10.3904/kjim.2019.105